Insider · CIK 0001808296

Farzan Nima

Reports to the SEC for 3 companies · THOUSAND OAKS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001808296

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	KROSKeros Therapeutics, Inc.S Sale	Director	SSale	−2,625 sh	$10.73	−$28.2K	9,767
2026-06-03	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,433 sh	—	—	7,433
2026-06-03	KROSKeros Therapeutics, Inc.A Award	Director	AAward	+7,142 sh	—	—	12,392
2025-06-04	KROSKeros Therapeutics, Inc.A Award	Director	AAward	+5,250 sh	—	—	5,250
2025-06-04	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2024-05-30	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−1.28M sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−750K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−400K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−275K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−437K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−2,186 sh	—	—	0
2023-06-06	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-02-10	Kinnate Biopharma Inc.Employee Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+750K sh	—	—	750,000
2023-02-10	Kinnate Biopharma Inc.Employee Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+750K sh	—	—	215,000
2022-06-01	KROSKeros Therapeutics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+8,293 sh	—	—	8,293
2022-02-11	Kinnate Biopharma Inc.Employee Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+400K sh	—	—	400,000
2021-06-01	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,293 sh	—	—	8,293
2021-02-12	Kinnate Biopharma Inc.Employee stock option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+275K sh	—	—	275,000
2020-05-29	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500

Recent filings

Accepted (ET)
Jun 84
Farzan Nima0001808296-26-000004
SEC(opens sec.gov)
Jun 54
Farzan Nima0001808296-26-000002
SEC(opens sec.gov)
Jun 64
Farzan Nima0001415889-25-015973
SEC(opens sec.gov)
Jun 34
Farzan Nima0001415889-24-015150
SEC(opens sec.gov)
Apr 54
Farzan Nima0001415889-24-010433
SEC(opens sec.gov)
Jun 84
Farzan Nima0001209191-23-035441
SEC(opens sec.gov)
Feb 154/A
Farzan Nima0001209191-23-009620
SEC(opens sec.gov)
Feb 144
Farzan Nima0001209191-23-009204
SEC(opens sec.gov)
Jun 34
Farzan Nima0001209191-22-034042
SEC(opens sec.gov)
Feb 154
Farzan Nima0001209191-22-009740
SEC(opens sec.gov)
Jun 34
Farzan Nima0001209191-21-037790
SEC(opens sec.gov)
Feb 164
Farzan Nima0001209191-21-010892
SEC(opens sec.gov)
May 294
Farzan Nima0001209191-20-032991
SEC(opens sec.gov)

Companies

Address

C/O LATIGO BIOTHERAPEUTICS, INC. 1300 RANCHO CONEJO BLVD., SUITE 305

THOUSAND OAKS, CA, 91320